Association of menopausal status, expression of progesterone receptor and ki67 to the clinical response to neoadjuvant chemotherapy in luminal breast cancer
Rev. bras. ginecol. obstet; 41 (12), 2019
Abstract Objective To identify the biomarkers of response to neoadjuvant chemotherapy in early luminal breast cancer. Methods A cross-sectional study that included all patients with early or locallyadvanced luminal breast cancer submitted to neoadjuvant chemotherapy between 2013 and 2014. Demographic...
Antineoplásicos/uso terapéutico, Neoplasias de la Mama/tratamiento farmacológico, Neoplasias de la Mama/genética, Quimioterapia Adyuvante, Estudios Transversales, Expresión Génica, Antígeno Ki-67/genética, Antígeno Ki-67/metabolismo, Menopausia, Persona de Mediana Edad, Terapia Neoadyuvante, Receptor ErbB-2/genética, Receptor ErbB-2/metabolismo, Receptores de Estrógenos/genética, Receptores de Estrógenos/metabolismo, Receptores de Progesterona/genética, Receptores de Progesterona/metabolismo